Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-09-03 19:09:24 ET · period of report 2026-09-03 · accession 0001193125-26-382277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-03 19:09 | 2026-09-03 | AXSM | Jacobson Mark L. | COO | M - OptEx | $12.95 | +10.0K | 10.0K | New | +$129.5K |
| DT | 2026-09-03 19:09 | 2026-09-03 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $208.65 | -10.0K | 0 | -100% | -$2.09M |
| DT | 2026-09-03 19:09 | 2026-09-03 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -10.0K | 105.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-03 | M | A | 10,000 | $12.95 | 10,000 | D | — | — | (F1) Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. |
| 2 | Common | Common Stock | 2026-09-03 | S | D | 10,000 | $208.65 | 0 | D | — | — | (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. (F3) Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $206.41 and $210.34. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-09-03 | M | D | 10,000 | $0.00 | 104,954 | D | $12.95 · 2020-03-19 to 2029-03-19 | 10,000 Common Stock | (F1) Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options. (F2) Such transaction was pursuant to a pre-approved 10b5-1 plan. |